|
|
|
|
Impact of Nicotine Replacement Therapy on Postoperative Mortality Following Coronary Artery Bypass Graft Surge
Print Save in My Library Free Abstract Paciullo CA et al.- The use of NRT in a postoperative CABG surgery population resulted in a significant increase in mortality when adjusted for baseline characteristics. Patients receiving NRT...
|
|
|
DID YOU KNOW: FDA Approves ACTOplus met(R) XR Tablets for the Treatment of Type 2 Diabetes
Another 'not new' drug, but new combination added to the arsenal for treating diabetes.Takeda Pharmaceutical have announced that the FDA approved an extended-release version of the combination medication ACTOplus met(R) (pioglitazone HCl...
|
|
|
Bisphenol A Implicated in Breast and Prostate Cancer: 'Ban It Now,' Urges Dr. Kathleen T. Ruddy
-- The Breast Health and Healing Foundation, (BH&HF) (www.breasthealthandhealing.com) today called for the immediate ban of Bisphenol A, or BPA, a chemical used as a hardening agent in many common plastic products.Kathleen T. Ruddy,...
|
|
|
Baxter To Acquire Continuous Renal Replacement Therapy Business From Edwards Lifesciences
Baxter International Inc.(NYSE:BAX) announced today a definitive agreement with Edwards Lifesciences Corporation (NYSE:EW) under which Baxter will acquire certain assets related to Edwards' hemofiltration product line, also known as...
|
|
|
Genomic Health Reports Favorable Commentary on Value of Multigene Assays From the St. Gallen Expert Consensus
- Guidelines Specify that Validated Molecular Assays Should be Considered as an Adjunct to Standard Measures in Helping Determine Chemotherapy Benefit - GENEVA, and REDWOOD CITY, Calif., June 26 /PRNewswire-FirstCall/ -- Genomic Health, Inc....
|
|
|
Genomic Health Reports Favorable Commentary on Value of Multigene Assays From the St. Gallen Expert Consensus
- Guidelines Specify that Validated Molecular Assays Should be Considered as an Adjunct to Standard Measures in Helping Determine Chemotherapy Benefit - GENEVA, and REDWOOD CITY, Calif., June 26 /PRNewswire-FirstCall/ -- Genomic Health, Inc....
|
|
|
Genomic Health Reports Favorable Commentary on Value of Multigene Assays From the St. Gallen Expert Consensus
- Guidelines Specify that Validated Molecular Assays Should be Considered as an Adjunct to Standard Measures in Helping Determine Chemotherapy Benefit - GENEVA, and REDWOOD CITY, Calif., June 26 /PRNewswire-FirstCall/ -- Genomic Health, Inc....
|
|
|
Genomic Health Reports Favorable Commentary on Value of Multigene Assays From the St. Gallen Expert Consensus
- Guidelines Specify that Validated Molecular Assays Should be Considered as an Adjunct to Standard Measures in Helping Determine Chemotherapy Benefit - GENEVA, and REDWOOD CITY, Calif., June 26 /PRNewswire-FirstCall/ -- Genomic Health, Inc....
|
|
|
Genomic Health Reports Favorable Commentary on Value of Multigene Assays From the St. Gallen Expert Consensus
- Guidelines Specify that Validated Molecular Assays Should be Considered as an Adjunct to Standard Measures in Helping Determine Chemotherapy Benefit - GENEVA, and REDWOOD CITY, Calif., June 26 /PRNewswire-FirstCall/ -- Genomic Health, Inc....
|
|
|
Genomic Health Reports Favorable Commentary on Value of Multigene Assays From the St. Gallen Expert Consensus
- Guidelines Specify that Validated Molecular Assays Should be Considered as an Adjunct to Standard Measures in Helping Determine Chemotherapy Benefit - GENEVA, and REDWOOD CITY, Calif., June 26 /PRNewswire-FirstCall/ -- Genomic Health, Inc....
|
|
|
Genomic Health Reports Favorable Commentary on Value of Multigene Assays From the St. Gallen Expert Consensus
- Guidelines Specify that Validated Molecular Assays Should be Considered as an Adjunct to Standard Measures in Helping Determine Chemotherapy Benefit - GENEVA, and REDWOOD CITY, Calif., June 26 /PRNewswire-FirstCall/ -- Genomic Health, Inc....
|
|
|
Genomic Health Reports Favorable Commentary on Value of Multigene Assays From the St. Gallen Expert Consensus
- Guidelines Specify that Validated Molecular Assays Should be Considered as an Adjunct to Standard Measures in Helping Determine Chemotherapy Benefit - GENEVA, and REDWOOD CITY, Calif., June 26 /PRNewswire-FirstCall/ -- Genomic Health, Inc....
|
|
|
Genomic Health Reports Favorable Commentary on Value of Multigene Assays From the St. Gallen Expert Consensus
- Guidelines Specify that Validated Molecular Assays Should be Considered as an Adjunct to Standard Measures in Helping Determine Chemotherapy Benefit - GENEVA, and REDWOOD CITY, Calif., June 26 /PRNewswire-FirstCall/ -- Genomic Health, Inc....
|
|
|
Genomic Health Reports Favorable Commentary on Value of Multigene Assays From the St. Gallen Expert Consensus
- Guidelines Specify that Validated Molecular Assays Should be Considered as an Adjunct to Standard Measures in Helping Determine Chemotherapy Benefit - GENEVA, and REDWOOD CITY, Calif., June 26 /PRNewswire-FirstCall/ -- Genomic Health, Inc....
|
|
|
Genomic Health Reports Favorable Commentary on Value of Multigene Assays From the St. Gallen Expert Consensus
- Guidelines Specify that Validated Molecular Assays Should be Considered as an Adjunct to Standard Measures in Helping Determine Chemotherapy Benefit - GENEVA, and REDWOOD CITY, Calif., June 26 /PRNewswire-FirstCall/ -- Genomic Health, Inc....
|
|
|
Genomic Health Reports Favorable Commentary on Value of Multigene Assays From the St. Gallen Expert Consensus
- Guidelines Specify that Validated Molecular Assays Should be Considered as an Adjunct to Standard Measures in Helping Determine Chemotherapy Benefit - GENEVA, and REDWOOD CITY, Calif., June 26 /PRNewswire-FirstCall/ -- Genomic Health, Inc....
|
|
|
Genomic Health Reports Favorable Commentary on Value of Multigene Assays From the St. Gallen Expert Consensus
- Guidelines Specify that Validated Molecular Assays Should be Considered as an Adjunct to Standard Measures in Helping Determine Chemotherapy Benefit - GENEVA, and REDWOOD CITY, Calif., June 26 /PRNewswire-FirstCall/ -- Genomic Health, Inc....
|
|
|
Genomic Health Reports Favorable Commentary on Value of Multigene Assays From the St. Gallen Expert Consensus
GENEVA, andREDWOOD CITY, Calif., June 26 /PRNewswire-FirstCall/ -- Genomic Health, Inc.(Nasdaq: GHDX) today reported that the St. Gallen International Consensus Panel on the Primary Therapy of Early Breast Cancer recommended for...
|
|
|
Genomic Health Reports Favorable Commentary on Value of Multigene Assays From the St. Gallen Expert Consensus
- Guidelines Specify that Validated Molecular Assays Should be Considered as an Adjunct to Standard Measures in Helping Determine Chemotherapy Benefit - GENEVA, and REDWOOD CITY, Calif., June 26 /PRNewswire-FirstCall/ -- Genomic Health, Inc....
|
|
|
Genomic Health Reports Favorable Commentary on Value of Multigene Assays From the St. Gallen Expert Consensus
- Guidelines Specify that Validated Molecular Assays Should be Considered as an Adjunct to Standard Measures in Helping Determine Chemotherapy Benefit - GENEVA, and REDWOOD CITY, Calif., June 26 /PRNewswire-FirstCall/ -- Genomic Health, Inc....
|
|
|
Genomic Health Reports Favorable Commentary on Value of Multigene Assays From the St. Gallen Expert Consensus
- Guidelines Specify that Validated Molecular Assays Should be Considered as an Adjunct to Standard Measures in Helping Determine Chemotherapy Benefit - GENEVA, and REDWOOD CITY, Calif., June 26 /PRNewswire-FirstCall/ -- Genomic Health, Inc....
|
|
|
Genomic Health Reports Favorable Commentary on Value of Multigene Assays From the St. Gallen Expert Consensus
- Guidelines Specify that Validated Molecular Assays Should be Considered as an Adjunct to Standard Measures in Helping Determine Chemotherapy Benefit - GENEVA, and REDWOOD CITY, Calif., June 26 /PRNewswire-FirstCall/ -- Genomic Health, Inc....
|
|
|
Genomic Health Reports Favorable Commentary on Value of Multigene Assays From the St. Gallen Expert Consensus
- Guidelines Specify that Validated Molecular Assays Should be Considered as an Adjunct to Standard Measures in Helping Determine Chemotherapy Benefit - GENEVA, and REDWOOD CITY, Calif., June 26 /PRNewswire-FirstCall/ -- Genomic Health, Inc....
|
|
|
Genomic Health Reports Favorable Commentary on Value of Multigene Assays From the St. Gallen Expert Consensus
- Guidelines Specify that Validated Molecular Assays Should be Considered as an Adjunct to Standard Measures in Helping Determine Chemotherapy Benefit - GENEVA, and REDWOOD CITY, Calif., June 26 /PRNewswire-FirstCall/ -- Genomic Health, Inc....
|
|
|
Genomic Health Reports Favorable Commentary on Value of Multigene Assays From the St. Gallen Expert Consensus
- Guidelines Specify that Validated Molecular Assays Should be Considered as an Adjunct to Standard Measures in Helping Determine Chemotherapy Benefit - GENEVA, and REDWOOD CITY, Calif., June 26 /PRNewswire-FirstCall/ -- Genomic Health, Inc....
|
